Quanterix (QTRX) Shareholder's Equity Growth (1y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Quanterix | 165.84 Mn | 66.57 Mn | 15.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.83% |
| Dec 31, 2025 | -10.40% |
| Sep 30, 2025 | -7.18% |
| Jun 30, 2025 | -14.18% |
| Mar 31, 2025 | -7.86% |
| Dec 31, 2024 | -5.69% |
| Sep 30, 2024 | -3.94% |
| Jun 30, 2024 | -3.67% |
| Mar 31, 2024 | -3.33% |
| Dec 31, 2023 | -2.23% |
| Sep 30, 2023 | -4.98% |
| Jun 30, 2023 | -12.76% |
| Mar 31, 2023 | -17.10% |
| Dec 31, 2022 | -19.16% |
| Sep 30, 2022 | -18.49% |
| Jun 30, 2022 | -12.99% |
| Mar 31, 2022 | -9.12% |
| Dec 31, 2021 | 115.13% |
| Sep 30, 2021 | 117.91% |
| Jun 30, 2021 | 319.70% |
| Mar 31, 2021 | 296.04% |
| Dec 31, 2020 | 59.98% |
| Sep 30, 2020 | 53.44% |
| Jun 30, 2020 | 48.55% |
| Mar 31, 2020 | 247.94% |
| Dec 31, 2019 | 213.30% |
| Sep 30, 2019 | 185.68% |
| Jun 30, 2019 | 40.56% |
| Mar 31, 2019 | -42.33% |
| Dec 31, 2018 | -37.65% |
| Dec 31, 2017 | 157.22% |